Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,362 | -2,423 | -13,986 | -11,133 | -8,566 |
| Depreciation Amortization | 408 | 228 | 984 | 762 | 495 |
| Accounts receivable | -334 | -246 | 184 | 249 | 87 |
| Other Working Capital | -736 | -598 | -3,508 | -2,300 | -1,919 |
| Other Operating Activity | -3,642 | -171 | 1,032 | 1,273 | 1,639 |
| Operating Cash Flow | $-5,666 | $-3,210 | $-15,294 | $-11,149 | $-8,264 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -7,525 | -5,002 | -5,002 |
| PPE Investments | 146 | 4 | 110 | 37 | 32 |
| Net Acquisitions | 2,000 | N/A | 569 | 569 | 569 |
| Sale Of Investment | 2,501 | N/A | 2,502 | N/A | N/A |
| Investing Cash Flow | $4,647 | $4 | $-4,344 | $-4,396 | $-4,401 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5 | 5 | 6,009 | 6,009 | 6,002 |
| Other Financing Activity | 0 | 0 | -497 | -497 | -497 |
| Financing Cash Flow | $5 | $5 | $5,512 | $5,512 | $5,505 |
| Beginning Cash Position | 6,518 | 6,518 | 20,644 | 20,644 | 20,644 |
| End Cash Position | 5,504 | 3,317 | 6,518 | 10,611 | 13,484 |
| Net Cash Flow | $-1,014 | $-3,201 | $-14,126 | $-10,033 | $-7,160 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,666 | -3,210 | -15,294 | -11,149 | -8,264 |
| Capital Expenditure | -16 | -13 | -5 | -5 | -5 |
| Free Cash Flow | -5,682 | -3,223 | -15,299 | -11,154 | -8,269 |